DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.05% to $167.95 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.35% to 7,592.40 and Dow Jones Industrial Average falling 0.36% to 52,297.09.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 4.89% short of its 52-week high of $176.58, which the company achieved on November 5th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.11% to $283.52, Pfizer Inc. $(PFE)$ fell 2.11% to $28.83, and Abbott Laboratories $(ABT)$ fell 1.87% to $107.25.
Trading volume (4.2 M) remained 2.0 million below its 50-day average volume of 6.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 12, 2026.
Comments